Starting in July 2026, eligible Medicare beneficiaries will gain access to certain weight-loss medications for $50 a month through a temporary initiative called the Medicare GLP-1 Bridge program
Br J Cancer 95 (Suppl 1): S13S19
A small retrospective study in Japan reported that dulaglutide 0.75 mg improved liver enzymes, glucose metabolism, and liver stiffness in patients with MASLD and T2DM after 12 weeks
Curr Atheroscler Rep
So then, they at least have oversight and are regulated by the State Board of Pharmacy. Moore also advises checking the State Board of Pharmacy website (for whichever state the business resides) for consumer complaints and inspection violations
Evidence level: Unsupported by the cited record Sources: Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice., Nicotinamide N-methyltransferase inhibition mitigates obesity-related metabolic dysfunction., ClinicalTrials.gov exact-name search, accessed 2026-07-12 How to read this: Direct efficacy findings come from obese mice, not human trials
